二尖瓣脱垂、室性心律失常与心脏性猝死
本文综述了心律失常性二尖瓣脱垂(MVP)的临床特征、病理生理机制与治疗挑战。MVP在普通人群中的超声检出率为2%~3%,但心律失常性MVP的真实负担、危险分层和治疗尚不明确。临床挑战在于识别心律失常性MVP患者并预防猝死,需前瞻性多中心研究评估心脏磁共振、电生理检查及靶向治疗的价值。
要点
- 心律失常性MVP常见于女性,多为双叶黏液样病变,伴中晚期收缩期喀喇音、下壁导联复极异常及复杂室性心律失常,无明显反流。
- 左室乳头肌及下基底壁纤维化、二尖瓣环分离和收缩期卷曲是电不稳定的重要病理生理机制。
- 浦肯野纤维起源的室性早搏可作为室颤触发因素,基质与机械牵张触发共同导致恶性心律失常。
核心结论
- 心律失常性MVP的真实负担、危险分层和治疗尚不明确,识别高危患者并预防猝死是主要临床挑战。
研究设计与样本
- 综述性文章,总结了心律失常性MVP的临床特征、病理生理机制及治疗挑战。
主要发现
- 心律失常性MVP患者通常为女性,多为双叶黏液样病变,伴中晚期收缩期喀喇音、下壁导联复极异常及复杂室性心律失常,无明显反流。
- 病理和心脏磁共振研究在猝死受害者及心律失常性MVP患者中描述了左室乳头肌及下基底壁纤维化、二尖瓣环分离和收缩期卷曲。
- 电生理研究记录到浦肯野组织起源的室性早搏作为室颤触发因素,见于心脏骤停复苏的MVP患者。
临床怎么用
- 临床需识别心律失常性MVP患者,选择合适影像技术(如心脏磁共振)评估基质,并考虑靶向导管消融或二尖瓣手术以降低危及生命心律失常风险。
局限性
- 心律失常性MVP的真实负担、危险分层和治疗尚不明确,需前瞻性多中心研究评估心脏磁共振和电生理检查的预后价值及靶向治疗疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite a 2% to 3% prevalence of echocardiographically defined mitral valve prolapse (MVP) in the general population, the actual burden, risk stratification, and treatment of the so-called arrhythmic MVP are unknown. The clinical profile is characterized by a patient, usually female, with mostly bileaflet myxomatous disease, mid-systolic click, repolarization abnormalities in the inferior leads, and complex ventricular arrhythmias with polymorphic/right bundle branch block morphology, without significant regurgitation. Among the various pathophysiologic mechanisms of electrical instability, left ventricular fibrosis in the papillary muscles and inferobasal wall, mitral annulus disjunction, and systolic curling have been recently described by pathological and cardiac magnetic resonance studies in sudden death victims and patients with arrhythmic MVP. In addition, premature ventricular beats arising from the Purkinje tissue as ventricular fibrillation triggers have been documented by electrophysiologic studies in MVP patients with aborted sudden death. The genesis of malignant ventricular arrhythmias in MVP probably recognizes the combination of the substrate (regional myocardial hypertrophy and fibrosis, Purkinje fibers) and the trigger (mechanical stretch) eliciting premature ventricular beats because of a primary morphofunctional abnormality of the mitral valve annulus. The main clinical challenge is how to identify patients with arrhythmic MVP (which imaging technique and in which patient) and how to treat them to prevent sudden death. Thus, there is a necessity for prospective multicenter studies focusing on the prognostic role of cardiac magnetic resonance and electrophysiologic studies and on the therapeutic efficacy of targeted catheter ablation and mitral valve surgery in reducing the risk of life-threatening arrhythmias, as well as the role of implantable cardioverter defibrillators for primary prevention.
引用
- Basso C, Iliceto S, Thiene G, et al. Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death. Circulation. 2019. PMID: 31498700. doi:10.1161/CIRCULATIONAHA.118.034075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。